Genuit Share Discussion Threads

[shirtless dan] 04/8/2005 09:32

What interest does rambutan have in sphere?

[rambutan2] 03/8/2005 17:30

been some instit share dealings going on over last couple of weeks.
prob in for a nudge up if all completed.

[rambutan2] 15/7/2005 09:41

all sounding quite bullish on the cmr front.

[maxwellsdemon] 15/7/2005 08:17

RNS Number:9021O
Generics Group AG
15 July 2005


Generics' award winning spin-out CMR Fuel Cells Ltd successfully completes
Series B financing

The Generics Group AG, a leading integrated technology consulting, development
and investment organisation, is pleased to announce that its spin-out company,
CMR Fuel Cells Ltd ('CMR'), winner of the 2005 Carbon Trust Innovation Award,
has successfully completed a Series B financing from a syndicate of
institutional and individual investors.

Generics invested #250,000 in the series B round and maintains a 16.4% equity
stake in CMR post the financing. Co-investors in the series B round include
Herald Ventures II LLP acting through its general partner and manager Herald
G.P. II Limited, Conduit Ventures and the Carbon Trust in addition to other
funds managed by Generics. The BVCA value of CMR in Generics' portfolio post
funding is #1.0m (Q1 2005 CMR BVCA #0.1m).

The funding is a major step forward in CMR's mission to make mass-market fuel
cells commercially viable for the first time. CMR's world-leading technology
gives OEMs and manufacturers the option to integrate cost effective, long
running and energy efficient fuel cell solutions into a wide range of consumer
electronic products. The funds will be used to strengthen and accelerate CMR's
technical and commercial development.

"We are tremendously excited to be working with such a high-capability group of
investors who share our vision of CMR technology driving the uptake of fuel
cells in mass-market portable electronics. They bring financial, strategic and
commercial resources which significantly enhance CMR's ability to realise our
goal" said John Halfpenny, CEO of CMR Fuel Cells.

Martin Frost, Managing Director, The Generics Group, added "I am delighted that
the technical and commercial progress of CMR over the last 18 months has been
recognised in the Series B financing. We believe that CMR will become a leading
supplier of fuel cell products based on revolutionary stack architecture. In the
short term this will enhance the BVCA valuation of our portfolio by around #1m.
In the longer term CMR is capable of creating significant wealth for itself, its
customers and its investors."

[rambutan2] 24/6/2005 11:00

1st quarters out.
look fine to me.
consultancy stuff going fine, mortgage now covered by rent, blue sky cos on books for v little ie cmr at £100k, nav 9.2p or 12.3p using bvca valuations.

[adejuk] 12/6/2005 12:58

i also have the t shirt ram!
:-)

[rambutan2] 08/6/2005 11:22

cheers adejuk, but of course with meds/bios it's always a big if - i speak as a man of many disappointments in the sector over the years!

[adejuk] 08/6/2005 11:11

nudge, nudge, wink wink, say no more, say no more.
:-)
no mystery guys. just research into the company and its market potential. if they can bring it to market it really will revolutionise treatment protocols in hospitals around the globe. huge market. it's all about marketing - the product range is fantastic.

[rambutan2] 08/6/2005 10:35

yes, agree that sphere looks v promising, it was just adejuk choosing to make predictions that intrigued me.

am fairly sure that its the former, not (unfortunately) the latter. but as you say, it's good pr.

[elgordo] 08/6/2005 10:28

I have to admit that whilst I've spent a lot of time looking at CMR and Atraverda, I didn't know much about Sphere, but a quick nose around their website (www.spheremedical.com) does provide grounds for optimism about their potential. Unlike many "blue sky" pharmas, Sphere's technolgies are already well advanced, having originally been developed by Siemens, and in their 20/5/04 press release regarding the winning of a DTI Exceptional Development Project Award, they stated that the Proxima System (for online blood parameter analysis)"is expected to be launched on the world markets in late 2006."

On a seperate subject, does anyone know what the typical commercial arrangements are between Scientific Generics and their clients (e.g. Hornby, Boardbug, Telsecure)? Is it simply professional services work, or does Generics get a share of future revenues of these products? If the former, these are all good adverts for their consulting skills to help attract future work, but the later model would create potential for on-going (and growing) revenues straight to the bottom line.

[loss-leader] 08/6/2005 10:12

another bit of product news



P

[rambutan2] 08/6/2005 10:08

why you so bullish/confident about sphere adejuk. what you heard?

[adejuk] 07/6/2005 19:16

of course the q is rhetorical. this is a no brainer at this silly price. bottom draw and come back in 18 months.

[adejuk] 07/6/2005 19:15

am i right in thinking that gen holds a 10% stake in sphere medical holdings?
if so this is a potential gold mine when sphere floats.

[maxwellsdemon] 05/6/2005 11:44

Mobile technology solution to stamp out 'card not present' fraud
2 June 2005
With Chip & PIN already making significant inroads against card fraud, Ingenico, the world’s leading supplier of secure transactions, has signed a distribution deal with Telsecure to distribute securePay™, technology developed with Scientific Generics, which uses the existing mobile phone network for card transactions.

‘Card not present’ transactions; payments made by telephone, mail order and the internet, remains the biggest type of fraud in the UK, having risen by 24 per cent from £122 million to £150 million since 2003.*

Scientific Generics and Telsecure worked together to create and implement securePay™ – a totally new approach to securing card transactions which uses the cardholder’s mobile phone as part of the authentication process. Transaction security is greatly increased and involves the customer directly in the authorisation, even if being performed remotely.

The simplicity of securePay™ is its strength. The solution works with existing payment systems for ‘card present’ and ‘card not present’ transactions, and links a users credit card number with their mobile phone. When a card is presented for payment the user receives a message on their mobile authorising the transaction.

Ingenico already provides secure payment solutions to all the major UK banks including HBOS, Barclays, HSBC and Alliance and Leicester, enabling a fast rollout of the new authentication system.


2%20June%202005



EventsThe Rainbow Bridge - connecting excellence in Cambridge and China
28 June 2005

Generics is hosting an event looking at the growing links between the home of world-class innovation at Cambridge and the world-leading manufacturing strength of China.

Presentations will cover a number of topics about the relationship and opportunities between the East and West, with discussion on: dispelling the fears of off-shoring; research, innovation and technology transfer in the UK; and the case for investment in Hong Kong.

The event will also showcase SGAI Tech Ltd, a new joint venture between Scientific Generics in Cambridge, UK and Automatic Manufacturing Ltd in Hong Kong and China.

Tuesday 28 June 2005
9.30am - 2pm

28%20June%202005

[rambutan2] 02/6/2005 20:49

interesting elgordo, thanks for those.
cmr does appear to have BIG potential. although early days of course.

[elgordo] 02/6/2005 15:58

In advance of making a small increase in my Generics holding today, I have been digging around for additional information on two of their core investments:

Atraverda
Until recently, the Atraverda website had not been updated since 2003 and gave the impression there was no activity or progress, but they have now completely updated the site, at . This follows their latest funding round at the end of 2004, and their relocation to Wales. The following articles give details - http://www.sep.co.uk/venturer/news_atraverda.html
and (ninth article - "Jump start to jobs in Gwent"). Interesting to note that these articles state that Atraverda "is preparing to launch its first commercial product in 2005" and "production will start some time between April and June".

CMR Fuel Cells
This has been getting a fair amount of publicity recently, having won the Carbon Trust Award 2005 and been included in the Red Herring Top 100 European Private Technology Companies list (as posted by others, above). As for product progress, I also notice here - - that "CMR plans to showcase a high performance prototype this summer, but final release plans haven't been set", and here - - that "CMR was in talks about possible demonstrations for the Defense Department".
Whilst it is very simplistic to make comparisons between different companies in the same sector, I can't think of another way to assess the potential value of CMR. The other UK fuel cell company that has had a fairly high profile lately is Ceres Power (Epic: CWR). Ceres may be closer to commercialisation, in that it has engaged in testing for prospective clients, but it is currently valued at around £55 million. On the basis that Generics owns around 20% of CMR, if it were to achieve a similar valuation in due course, this would equate to around 5p per share.

[rambutan2] 25/5/2005 09:44

so, things still on track and looking up...

[loss-leader] 25/5/2005 09:35

Gordon Edge way the guy who created Generics. Although he has not been on theoperational side for a while, there are still people who think of it as 'his'company

ll

[maxwellsdemon] 02/5/2005 20:06

rambutan,

You could be right. Here is more on the Red Herring guff:

CMR Fuel Cells selected for prestigious Red Herring’s Top 100

12 April, 2005 - CMR Fuel Cells Ltd, today announced that it has been selected as one of Red Herring’s Top 100 private companies to watch in 2005. The Cambridge based company is developing pioneering fuel cell technology, set to deliver the low-cost, long run-time power solutions that today’s portable electronic products demand.
Through its unique, patented fuel cell technology CMR will make mass-market fuel cells commercially viable for the first time, reducing the cost of a fuel cell stack by up to 80% and the size by up to 90%. CMR’s products can be built using printing or roll-to-roll techniques – improving reliability and further reducing costs.
Every year, Red Herring's Top 100 sets the standard as the technology industry’s definitive list of private companies impacting the market place. The editorial team at Red Herring, the leading magazine of business technology and innovation, has selected companies that have demonstrated outstanding achievements since their inception, representing the most instrumental players in leading the technology industry.

Red Herring’s editorial staff rigorously evaluated more than 600 private companies through a careful analysis of financial data and subjective criteria, including quality of management, execution of strategy, and dedication to research and development. “We are delighted that Red Herring has recognised the validity of our vision of CMR delivering the promise of instant re-charge, long run-time and low cost to the portable electronics industry,” said John Halfpenny, CEO of CMR Fuel Cells Ltd. “We are poised to enable a new generation of products, for the first time exploiting the massive increases in power available from fuel cells when compared with traditional battery power.”

“Our list shows that despite obstacles posed by regulations, bureaucracy and tradition, innovation and entrepreneurship continues to thrive in Europe,” said Red Herring editor-in-chief Joel Dreyfuss. Red Herring’s lists of top private companies are an important part of the magazine’s tradition of identifying new and innovative technology companies and entrepreneurs. Companies like Google and eBay were spotted in their early days by Red Herring editors as those that would change the way we live and work. This is the first time that Red Herring magazine has compiled a list focused exclusively on the most promising start-ups in Europe.

About CMR Fuel Cells

CMR Fuel Cells Limited is a UK developer of fuel cell stacks for portable and small stationary power generation applications. The company plans to become a leading supplier of fuel cell technology and products, based on its simple but revolutionary stack architecture and through its relationships with other key organisations.

CMR Fuel Cells Limited was incorporated in October 2003, based on technology developed over the preceding four years at the Generics Group in Cambridge, UK. The company is owned by the management team, Conduit Ventures Limited, Carbon Trust Investments, and the Generics Group. Conduit Ventures is a specialist venture capital fund focusing on fuel cells backed by Johnson Matthey, Shell Hydrogen, Mitsubishi, Danfoss, and Solvay.

Carbon Trust Investments is a leader in clean energy investing and is funded by the UK government. Generics is a leading European technology and management consultancy located in Cambridge, UK.

For more details, please visit www.cmrfuelcells.com

About Red Herring

Red Herring, Inc., founded in 1993, is a media company whose mission is to cover innovation, technology, financing and entrepreneurial activity. Its staff of award-winning journalists tell readers what's first, what matters and most importantly, why.

Red Herring is dedicated to thorough research, relevant metrics deep financial analysis, indepth reporting, crisp writing and thoughtful debate. We are a skeptical, intelligent and trustworthy source of information in technology business. Our primary obligation is to provide the most relevant, honest and independent information and analysis to our audience, with the conviction that an exceptional editorial product is the best catalyst for success and the best way to serve our advertisers and investors. Our content is original, compelling and actionable for industry executives and entrepreneurs.

A privately held company, Red Herring, Inc. is headquartered in Belmont, California. For more information visit

[rambutan2] 25/4/2005 15:02

cmr could be a biggie. hope gen doesnt keep diluting its stake down...
25 April 2005

CMR Fuel Cells wins Carbon Trust Innovation Award 2005

The Generics Group AG ('Generics' LSE: GEN.L), a leading integrated technology
consulting, development and investment organisation, is pleased to announce that
its spin-out portfolio company, CMR Fuel Cells Limited ('CMR') has been awarded
the Carbon Trust Innovation Award for 2005. CMR was spun out of Generics in Q1
2004 to exploit a revolutionary flow-through cell utilising mixed reactants.
Generics retains an equity holding of 20% after financing received from The
Carbon Trust and Conduit Ventures.

Through its patented fuel cell technology, CMR seeks to make fuel cells
commercially viable for the first time, reducing the cost of a fuel cell stack
by up to 80% and the size by up 90%. CMR's products can be built using printing
or roll-up techniques, improving reliability further. CMR plans to become a
leading supplier of fuel cell technology and products based on its simple but
revolutionary stack architecture and through its relationship with other key
organisations.

Commercial fuel cell revenues are projected to grow to over $14 billion by 2010.
CMR will address this market with what is widely recognised as one of the
industry's leading commercial mass market technology propositions. In Q3 2004
CMR appointed John Halfpenny as CEO - John is an experienced entrepreneur with a
successful track record and significant experience in the consumer electronics
sector. Latterly John was a director of embedded software at ARM plc and CEO of
Splashpower.

CMR Fuel Cells has also been selected as one of Red Herring's Top 100 private
companies to watch in 2005.

[rambutan2] 19/4/2005 16:20

re spring newsletter. well worth reading the piece on the hong kong/china venture, it looks as though it has quite exciting potential.

by chance spoke to katie potts of herald it the other day and she confirmed that she does have a holding in gen, it doesnt show up anywhere because it held by the management company and not the trust. she said she though gen interesting and liked some of the vc gen has - remember that she runs a vc fund herself.

[rambutan2] 19/4/2005 16:08

due to election it's been dropped, but will im sure be back...

Scientific Generics comment on the ID Cards Bill - We have the technology
21 March 2005
Scientific Generics comment on the ID Cards Bill getting its second reading

If Identity Cards are introduced in Britain they will rely on advanced biometric techniques, such as eye, finger, and face scanning to make them as secure as possible. One of the key arguments against their introduction is the prohibitively high costs involved, not at least the expense of creating and maintaining a database to store information about every citizen.

But a Cambridge firm, Scientific Generics, believes it has developed the technology for the job, without the pitfalls of other systems.

John Greaves, Business Development Directors says, "There are, broadly speaking, three issues around the implementation of ID cards. These are privacy, because you and I may not want our personal information stored; security, an ID card system must be as 'uncrackable' as possible; and cost, the infrastructure required would be an immense cost on the public purse. A major challenge for any system using biometric data has always been to minimise errors of 'false accepts' or 'false rejects'. However, we have developed technology that helps to address all these issues by using cryptographic (sophisticated coding) techniques on the data to eliminate the requirement for storage. Instead it is used directly to generate your personal PIN, or key - the 'Bio-key. "

The Bio-key is created by generating a combination of repeatable numbers from analogue information such as; biometric data from eye, fingerprint of face scans. It includes a system to stop someone who steals an ID cards from reconstructing the owner's face from the information on the card.

No sensitive, personal data needs to be stored to use the Bio-key as, the company says, "you are your key"

and spring newsletter...

[rambutan2] 18/4/2005 13:36

also v upbeat piece about them in today's ft in special on the battery industry.